For the first time we showed that positivity for anti-IA2 only was associated with a clinical phenotype more similar to that found in type 2 diabetes, while the few subjects showing simultaneous positivity for GADA and anti-IA2 were more similar to type 1 diabetes. This evidence concerns the gene PTPRN and type 2 diabetes mellitus.